On April 22, 2022, Anthony Zook resigned from the board of directors of BioSig Technologies, Inc. . Mr. Zook's resignation was not the result of any disagreement regarding any matter relating to the Company's operations, policies, or practices. On April 28, 2022, Frederick Hrkac was appointed to the Board, effective as of the same date, to fill the vacancy on the Board as a result of Mr. Zook's resignation, to serve as a director of the Board for a term expiring at the 2022 annual meeting of the Company's stockholders, or until his successor is duly elected and qualified, or his earlier death, resignation or removal.

For Mr. Hrkac's service on the Board, Mr. Hrkac will receive compensation consistent with market practices of similarly situated companies that is consistent with the Company's non-employee director compensation policy as may be then in effect. In addition, Mr. Hrkac was granted 50,000 nonqualified stock options with a term of ten years, 50% of which vested immediately upon Mr. Hrkac's acceptance of the Board's offer of employment and 50% of which shall vest on the first anniversary of his appointment, provided Mr. Hrkac is still serving as a director on such date.